Andtbacka RH, Ross M, Agarwala SS, et al. A phase II multicentre trial of HF10, oncolytic virus immunotherapy, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma. SMR 2017, abstract SMR04-2.
Minder neoadjuvante therapie bij rectumcarcinoom door selectie op basis van MRI-criteria?
jul 2019 | Maag-darm-leveroncologie